Editorial: Characterization of HIV-1 variants: implications for HIV-1 prevention, treatment and cure

被引：0
|
作者：
Mann, Jaclyn K. [1 ]
Tongo, Marcel [2 ]
Ueno, Takamasa [3 ,4 ]
机构：
[1] Univ KwaZulu Natal, HIV Pathogenesis Programme, Durban, South Africa
[2] Inst Med Res & Study Med Plants IMPM, Ctr Res Emerging & Reemerging Dis CREMER, Yaounde, Cameroon
[3] Kumamoto Univ, Joint Res Ctr Human Retrovirus Infect, Div Infect & Immun, Kumamoto, Japan
[4] Muhimbili Univ Hlth & Allied Sci MUHAS, Coll Med, Sch Diagnost Med, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania
来源：
FRONTIERS IN VIROLOGY | 2024年 / 4卷
关键词：
HIV-1; diversity; subtypes; transmission; drug resistance; latency establishment; HLA;
D O I：
10.3389/fviro.2024.1465702
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Origin of Minority Drug-Resistant HIV-1 Variants in Primary HIV-1 Infection
    Metzner, Karin J.
    Scherrer, Alexandra U.
    Preiswerk, Benjamin
    Joos, Beda
    von Wyl, Viktor
    Leemann, Christine
    Rieder, Philip
    Braun, Dominique
    Grube, Christina
    Kuster, Herbert
    Boeni, Juerg
    Yerly, Sabine
    Klimkait, Thomas
    Aubert, Vincent
    Furrer, Hansjakob
    Battegay, Manuel
    Vernazza, Pietro L.
    Cavassini, Matthias
    Calmy, Alexandra
    Bernasconi, Enos
    Weber, Rainer
    Guenthard, Huldrych F.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2013, 208 (07): : 1102 - 1112
  • [42] HIV-1 recombination in patients infected with multiple HIV-1 variants from the same donor
    Kearney, M.
    Shao, W.
    Maldarelli, F.
    Margolick, J.
    Daar, E.
    Mellors, J.
    Coffin, J.
    Palmer, S.
    [J]. ANTIVIRAL THERAPY, 2008, 13 (04) : A77 - A77
  • [43] Evaluation of the Xpert HIV-1 viral load assay on a wide panel of HIV-1 variants
    Gueudin, M.
    Baron, A.
    Alessandri-Gradt, E.
    Lemee, V.
    Mourez, T.
    Plantier, J. -C.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2015, 70 : S83 - S83
  • [44] HIV-1 cure strategies: why CRISPR?
    Atkins, Andrew J.
    Allen, Alexander G.
    Dampier, Will
    Haddad, Elias K.
    Nonnemacher, Michael R.
    Wigdahl, Brian
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (06) : 781 - 793
  • [45] Measuring the Success of HIV-1 Cure Strategies
    Thomas, Jordan
    Ruggiero, Alessandra
    Paxton, William A.
    Pollakis, Georgios
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2020, 10
  • [46] Targeted Immune Interventions for an HIV-1 Cure
    Perreau, Matthieu
    Banga, Riddhima
    Pantaleo, Giuseppe
    [J]. TRENDS IN MOLECULAR MEDICINE, 2017, 23 (10) : 945 - 961
  • [47] Analysis of HIV-1 variants by cloning DNA generated with the ViroSeq™ HIV-1 genotyping system
    Eshleman, SH
    Jones, D
    Flys, T
    Petrauskene, O
    Jackson, JB
    [J]. BIOTECHNIQUES, 2003, 35 (03) : 614 - +
  • [48] Reversal of Latency as Part of a Cure for HIV-1
    Rasmussen, Thomas Aagaard
    Tolstrup, Martin
    Sogaard, Ole Schmeltz
    [J]. TRENDS IN MICROBIOLOGY, 2016, 24 (02) : 90 - 97
  • [49] Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials
    Powell, Laura
    Dhummakupt, Adit
    Siems, Lilly
    Singh, Dolly
    Le Duff, Yann
    Uprety, Priyanka
    Jennings, Cheryl
    Szewczyk, Joseph
    Chen, Ya
    Nastouli, Eleni
    Persaud, Deborah
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2021, 139
  • [50] Neutralizing antibodies for HIV-1 prevention
    Julg, Boris
    Barouch, Dan H.
    [J]. CURRENT OPINION IN HIV AND AIDS, 2019, 14 (04) : 318 - 324
12345